Breast Cancer

I thought my sensitivity to breast cancer scenarios on television shows had gotten stronger, but it hasn’t.

After experiencing intense scanxiety after my single mastectomy, I decided to go back and have a prophylactic mastectomy.

Watch Dr. Naomi Dempsey, Dr. Ana Sandoval Leon, Dr. Rupesh Kotecha and Ricki Fairley answer questions about HER2-positive disease during the CURE Educated Patient® Breast Cancer Summit at MBCC.

After undergoing a partial mastectomy, scar tissue caused pain and stiffness. Then, I found a simple exercise that helped immensely.

I didn’t think that I’d lose my hair again after starting my latest breast cancer treatment, but I did — and with that hair loss came both new and familiar feelings.

Research backs up my personal experience regarding aging and cancer.

On Feb. 6, HB 2783 was introduced into the Arizona House. Hopefully this bill will help address some of the issues surrounding genetic testing, genetic counseling, and insurance coverage for those who might be at risk for hereditary cancer. My wife died of a cancer that was totally preventable. Nobody should die of a preventable cancer.

Researchers are recruiting patients with ER-positive, HER2-negative breast cancer to participate in a trial evaluating (Z)-endoxifen.

From comedian Chris Tucker teaming up with a nonprofit to educate Black men on their prostate cancer risk to Leeane Hainby and Rep. Jamie Raskin providing updates on their cancer treatment, here’s what’s happening in the cancer space this week.

Patients with cancer should keep a healthy heart during cancer treatment by exercising regularly and eating healthy, an expert emphasized.

Cancer often brings with it bad news, including expensive bills, but one day, a surprise came – one I’ll never forget.

From Senator Bob Casey undergoing prostate cancer surgery to a man giving away his Superbowl tickets to a good friend with stage 4 cancer, here’s what is happening in the oncology space this week.

Cancer brought me a forced transformation and gave me better a perspective on life.

When my wife was going through breast cancer treatment, I started drawing with my non-dominant hand as a means of distraction and self-care.

After meeting a woman who was forced to wait five months between finding a lump and being diagnosed with breast cancer, I wondered if that time affected the stage of her disease.

The hold has been placed due to visual side effects in a number of patients with solid tumors.

Orserdu demonstrated improved outcomes and quality of life for certain patients with metastatic breast cancer.

I’m working through one of the toughest times of my life. Perserverance is one of the many things that cancer has taught me.

The FDA approval of Trodelvy for patients with HR-positive, HER2-negative metastatic breast cancer provides patients with another treatment option after hormone therapy and standard chemotherapy.

After I was diagnosed with stage 4 breast cancer, clinicians told me I wouldn’t make it to my 35th birthday, but I recently did — and look forward to celebrating many more.

The use of PD-L1 to predict outcomes highlights a possible opportunity to better understand which patients with ER-positive breast cancer may benefit from an immune checkpoint inhibitor.

I don’t think of nature as a distraction to my cancer, masking the symptoms or the reality of my disease, but rather as a therapy that offers comfort and serenity with no negative side effects.

As a health care provider who specializes in lymphedema, I had a unique perspective when I was diagnosed with cancer.

Postmenopausal women cancer survivors, including lung, breast, colorectal and endometrial cancer, may have a greater physical function decline than is generally expected at their age, which may lead to lower quality of life after treatment.

As a part of its “Speaking Out” video series, CURE® spoke with genetic counselor, Angela Trepanier, on behalf of FORCE, to grasp a better understanding of what genetic breast cancer is and what it means for patients and their families.

As a part of its “Speaking Out” video series, on behalf of FORCE, CURE® spoke with Diane Rose, their vice president of volunteer programs about the importance of support for those affected by hereditary cancers.

As a part of its “Speaking Out” video series, CURE® spoke with genetic counselor, Angela Trepanier, on behalf of FORCE, about disparities seen in genetic testing for caner.

As a part of its “Speaking Out” video series, on behalf of FORCE, CURE® spoke with Diane Rose, their vice president of volunteer programs, about how advocacy partnerships can bring greater awareness and education to patients with cancer and their families.

As a part of its “Speaking Out” video series, on behalf of FORCE, CURE® spoke with Diane Rose, their vice president of volunteer programs, about clinical trials for patients with hereditary cancers and those who have a risk of developing.

Guidelines often use a cutoff of 70 years old for breast cancer treatment, but patients should discuss goals of care with their team to further personalize their care.